Cite
MLA Citation
P S Sever et al.. “5002Benefit of LDL-C lowering with evolocumab on cardiovascular outcomes by age & sex: an analysis of the FOURIER trial.” European heart journal, vol. 39, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100095502533.0x00003f